期刊文献+

2-甲氧基雌二醇逆转K562/AO2细胞耐药及其机制的初步研究

Mechanism of 2-methoxyestradiol Reversing Multidrug Resistance of K562/AO2 Cells
下载PDF
导出
摘要 目的研究2-甲氧基雌二醇(2-ME)对K562/AO2细胞耐药性逆转作用及其可能机制。方法利用不同浓度的2-ME作用于K562及K562/AO2细胞,MTT法检测细胞对阿霉素的耐药性,计算耐药倍数及逆转倍数;利用AnnexinV/PI双染色法检测K562/AO2细胞的凋亡效应。结果与K562细胞相比,K562/AO2细胞的耐药倍数为50倍;2-ME可显著降低阿霉素对K562/AO2细胞的IC50,逆转倍数为5.9倍。AnnexinV/PI双染色法检测显示,1、4、16μmol/L的2-ME处理K562/AO2细胞后细胞凋亡率分别为10.32%、21.56%和16.45%,而对照组凋亡率仅为6.68%。结论 2-ME能够逆转K562/AO2阿霉素耐药,其机制可能与诱导K562/AO2细胞凋亡有关。 Objective To investigate the possible mechanism of 2-methoxyestradiol reversing multidrug resistance of K562/AO2 cells.Methods The inhibitory effects of 2-methoxyestradiol on the proliferation of K562 and K562/AO2 cells were observed by MTT assay.Annexin V-FITC /PI staining was used to detect apoptosis.Results The resistance of K562/AO2 cells to ADR was 50 folds compared with K562 cells.The IC50 of ADR was evidently reduced by 2-methoxyestradiol.The reversal folds of 2-methoxyestradiol for K562/AO2 cells were 5.9.The result of Annexin-V /PI staining showed that rates of the apoptotic cells were 10.32%,21.56% and 16.45% respectively,which were remarkably higher than that of control(6.68%).Conclusion 2-methoxyestradiol has reverse effect on K562/AO2 cells,its possible mechanism might be related with apoptosis of K562/AO2 cells.
作者 王晓宁 张梅
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第11期1257-1259,共3页 Cancer Research on Prevention and Treatment
基金 西安交通大学医学院第一附属医院院基金资助项目(2007-YK-10)
关键词 2-甲氧基雌二醇 K562/AO2细胞 细胞凋亡 2-methoxyestradiol K562/AO2 cells Apoptosis
  • 相关文献

参考文献6

二级参考文献59

  • 1黄豪博,战榕.2-甲氧基雌二醇的抗肿瘤作用及机制研究[J].国际输血及血液学杂志,2006,29(3):204-206. 被引量:5
  • 2李栋梁,潘崚.2-甲氧基雌二醇对白血病细胞K562增生、凋亡及细胞周期的影响[J].白血病.淋巴瘤,2007,16(1):26-29. 被引量:6
  • 3Skorski T. BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability. Oncogene, 2002;21 : 8591 -8604
  • 4Zhou Y,Hileman EO,Plunkett W, et al. Free radical stress in chronic lymphocytic leukemia and its role in cellular sensitivity to ROS- generating anticancer agents. Blood,2003;101:4098 -4104
  • 5Lacasse EC, Kandimalla ER, Winocour P, et al. Application of X1AP antisense to cancer and other proliferative disorders: development of AEG35156/GEM640. Ann NY Acad Sci, 2005 ; 1058:215 - 234
  • 6Sattler M, Quinnan LR, Pride YB, et al. 2-medroxyestradiol alters cell motility, migration, and adhesion. Blood,2003 ; 102:289 - 296
  • 7Gao N, Rahmani M, Dent P,et al. 2-Methoxyestradiol-induced apoptisis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process. Oncogene ,2005 ;24:3797 - 3809
  • 8Gao N, Rahmani M, Shi X, et al. Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stress. Blood; 2006 ; 107:241 - 249
  • 9LaValee TM, Zhan XH, Herbstritt CJ, et al. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res,2002; 62:3691 -3697
  • 10Kumar AP, Garcia GE, Slaga TJ. 2-Methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells. Mol Carcinog,2001 ; 31 : 111 - 124

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部